Reporter Gong Mengze
On May 30, Zhongtong Bus reached the daily limit again to achieve 12 consecutive boards, and the transaction amount reached nearly 1.2 billion yuan.On the evening of the previous day, Zhongtong Bus issued a stock price change announcement. The company stated that the current products are mainly passenger cars, and the current sales volume of nucleic acid testing medical vehicles is relatively small, which has not had a significant impact on the company's operating performance.
In fact, this is the fourth time that Zhongtong Bus has issued a stock price change announcement this month.The "Securities Daily" reporter noticed that from May 13 to May 30, Zhongtong Bus has gained 12 daily limit, and the cumulative increase during the period has reached 214.52%.
Recently, although good news such as automobiles going to the countryside, reduction of purchase tax, and promotion of automobile consumption in many places have frequently appeared, which has stimulated the recovery of the automobile sector, the "12-connector" has obviously been separated from the fundamentals of Zhongtong Bus.In fact, the performance of Zhongtong Bus has been sluggish in recent years. Its net profit has been negative for five consecutive years, and its non-net profit has been negative for three consecutive years.The financial report shows that in 2021, the net profit of Zhongtong Bus will be -220 million yuan, a year-on-year decrease of 1033.23%.
4 change announcements
Unstoppable stock price soaring
With the new round of auto consumption stimulus policies in various places, the auto sector has accelerated to pick up recently, and many individual stocks in the auto sector have achieved daily limits.Among them, the increase of Zhongtong Bus not only leads the automobile sector, but also attracts attention with the amazing move of "12 consecutive boards".
The reporter of "Securities Daily" browsed the official website of Zhongtong Bus and found that as early as May 6, the company announced that during May 1st, Zhongtong Bus delivered 18 nucleic acid testing vehicles at one time (the above news has been deleted. ).Since then, investors have continuously inquired about the specific situation of the company's nucleic acid detection vehicle project through various channels.
On May 9, Zhongtong Bus stated on the investor interaction platform that the company currently has two medical vehicles that can be used for nucleic acid testing.The company's products sold in batches include two nucleic acid detection vehicles of 12 meters and 13 meters, all of which meet the P2+ biosafety laboratory standard, and have the functions of on-the-go collection, on-demand inspection, and on-the-go reporting.Zhongtong Bus also stated that the daily detection capacity of the 13-meter nucleic acid detection vehicle can reach 10,000 tubes, with a total of 100,000 passengers.
As we all know, currently promoting the layout of normalized nucleic acid sampling points and accelerating the construction of a "15-minute nucleic acid detection service circle" have become key tasks for epidemic prevention.Zhongtong Bus's statement this time directly detonated the skyrocketing market of "nucleic acid detection vehicle concept stocks".
Since May 13, Zhongtong Bus has started the continuous daily limit mode, and it has achieved an increase of up to 214.52% in only 12 trading days.As of the close on May 30, its share price has climbed to 13.65 yuan per share, with a market value of 8.093 billion yuan.
Facing the rising stock price, Zhongtong Bus issued a total of 4 stock price change announcements in May.The reporter noticed that in the previous three announcements, the company did not respond to the nucleic acid testing vehicle information that the market was concerned about, and repeatedly reiterated that no undisclosed material information that might have a greater impact on the stock price was found, and there was no violation information. Disclosure of Fair Disclosure Circumstances.It was not until May 29 that Zhongtong Bus explained the sales of nucleic acid testing vehicles for the first time in the announcement.
Net profit of Zhongtong Bus
5 consecutive years of negative growth
In response to the abnormal share price of Zhongtong Bus, the Shenzhen Stock Exchange issued a letter of concern on May 27 to question and monitor Zhongtong Bus.
The Shenzhen Stock Exchange stated that it is required to check whether the company’s controlling shareholders, actual controllers, directors, supervisors, senior executives and their immediate family members have traded the company’s stocks, and whether there is suspected insider trading; The material information disclosed, whether the fundamentals of the company have changed significantly.
In response to the recent content related to the nucleic acid detection vehicle business of Zhongtong Bus on the interactive platform, the Shenzhen Stock Exchange requires the company to explain the nucleic acid detection vehicle of Zhongtong Bus in combination with the production, revenue amount, proportion, and orders in hand of Zhongtong Bus. The business scale and its impact on the business development and profitability of Zhongtong Bus.
In addition, the Shenzhen Stock Exchange also requires the company to list and analyze the composition of the main products of Zhongtong Bus from 2022 to the present, including but not limited to main products, models, production, sales, corresponding operating income and its proportion, etc. There are industry policies that have a significant impact on passenger cars.
The reporter of "Securities Daily" found through the interactive platform that investors' questions and concerns about Zhongtong Bus mainly focused on nucleic acid testing vehicles, such as asking about sales and orders.From the reply of the secretary of the board of directors, it is not difficult to see that although the Zhongtong bus nucleic acid detection vehicle has certain advantages, its current scale is not large."The company's products include special medical vehicles, but the number is currently small, and the main products are passenger cars."
Talking about nucleic acid detection vehicles, Yutong Bus, the leader of domestic commercial vehicles, also stated that nucleic acid detection vehicles are special-purpose vehicles launched according to market demand, and belong to subdivided product models, but their sales volume accounts for a small proportion of total sales. have a large impact on performance.At the same time, although the market prospect of mobile nucleic acid detection equipment is optimistic, from a technical point of view, the transformation of nucleic acid detection vehicles is not difficult, and the market threshold is limited.Jiangling Motors, which has the reputation of "the first car in the fight against the epidemic", once stated that the light passenger chassis provided by the company is mainly used for conversion into medical ambulances, RVs and other models, including the conversion into mobile nucleic acid detection vehicles.
Focusing on the fundamentals of Zhongtong Bus, the company has recorded negative net profit growth for five consecutive years.By 2021, Zhongtong Bus will lose nearly 220 million yuan, and its performance will be the lowest since its listing.In the first quarter of this year, the company's net profit increased slightly by 11.12% year-on-year, but it still lost 35.287 million yuan, and the net profit after deduction has been negative for three consecutive years.
In terms of production and sales, in 2021, Zhongtong Bus will complete the sales of 10,050 buses, a year-on-year decrease of 3.99%.From January to April this year, the company achieved a cumulative sales volume of 2,257 units, a year-on-year increase of 2.5%.From the perspective of product structure, passenger cars are still the main products of the company.
"The continuous daily limit of Zhongtong Bus's stock price is obviously deviating from the company's fundamentals. Basically, hot money is 'making trouble'. Small-cap stocks like Zhongtong Bus are most suitable for short-term speculation." A securities auto analyst who did not want to be named told reporters , and hot money is often accompanied by high returns and high risks.Since the subsequent market changes are difficult to predict, after the hot money speculation, the follow-up share price and market share of Zhongtong Bus still need to rely on performance to speak.
(Editor in charge: Guan Jing)
